Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Jun. 30, 2024
shares
| |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On June 30, 2024, each of Shannon Morris, M.D., Ph.D., our Chief Medical Officer, and Ebun Garner, J.D., our General Counsel, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 80,000 and 200,000 shares of our common stock March 31, 2026 and June 30, 2026, respectively. |
| Rule 10b5-1 Arrangement Adopted | false |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Rule 10b5-1 Arrangement Modified | false |
| Non-Rule 10b5-1 Arrangement Modified | false |
| Shannon Morris [Member] | |
| Trading Arrangements, by Individual | |
| Name | Shannon Morris |
| Title | M.D., Ph.D., our Chief Medical Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | June 30, 2024 |
| Expiration Date | March 31, 2026 |
| Arrangement Duration | 640 days |
| Aggregate Available | 80,000 |
| Ebun Garner [Member] | |
| Trading Arrangements, by Individual | |
| Name | Ebun Garner |
| Title | J.D., our General Counsel |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | June 30, 2024 |
| Expiration Date | June 30, 2026 |
| Arrangement Duration | 731 days |
| Aggregate Available | 200,000 |